Carey Danis & Lowe is currently investigating Zofran birth defect cases, and is assisting families with filing Zofran birth defect lawsuits.
Zofran is an anti-nausea drug manufactured by GlaxoSmithKline, and was originally intended to prevent nausea and vomiting in patients undergoing chemotherapy.
Ondansetron, the active ingredient in Zofran, has been linked to birth defects in children.
A Swedish study, published in Reproductive Toxicology in December 2014, found that children exposed to Zofran in the womb had double the risk of developing a heart defect. The researchers also discovered that the most common heart defect was a hole in the heart, also known as an atrial or ventricular septal defect.
Another study published in 2013 by BioMed Research International found a 20% increased risk of children developing major birth defects if exposed to Zofran in the first trimester of pregnancy. Still, the researchers noted that they could not make a firm determination on the safety of Zofran for pregnant women based on their results.
Tomisha LeClair filed a Zofran birth defect lawsuit after her child was born with an atrial septal defect, among many other birth defects that included facial dysmorphia and hearing loss.
LeClair claimed that her child’s birth defects resulted from exposure to Zofran in the womb.
Many women like LeClair, along with their families, have filed lawsuits against GlaxoSmithKline. These lawsuits assert that the pharmaceutical giant marketed Zofran to pregnant women, and made the anti-nausea drug appear to be safe to use.
However, as these women discovered, Zofran is not safe for pregnant mothers and their unborn children.
You are not alone. You don’t have to suffer in silence.
The team of experienced Zofran lawyers at Carey Danis & Lowe work to recover losses for people like you. Contact our law firm for a free case evaluation. One of our Zofran lawyers can guide you through your legal options, and whether filing a Zofran birth defect lawsuit is right for you.
You can reach our law firm by phone at 800.721.2519, or by completing a confidential personal injury claim form.References: Pharmaceutical litigation, Zofran